Use of HSA-producing cells

The present invention refers to the area of cell culture technology and relates to methods for multiplying/cloning cells, preferably cell lines, which are important to the production of biopharmaceuticals. The invention further relates to methods for manufacturing proteins and to the use of cells ex...

Full description

Saved in:
Bibliographic Details
Main Authors BISCHOFF REBECCA, FIEDER JUERGEN, KAUFMANN HITTO, FLORIN LORE, KRIEG THOMAS
Format Patent
LanguageEnglish
Published 03.12.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention refers to the area of cell culture technology and relates to methods for multiplying/cloning cells, preferably cell lines, which are important to the production of biopharmaceuticals. The invention further relates to methods for manufacturing proteins and to the use of cells extracted and multiplied through single cell sorting and to media compositions that enable a multiplication of single cells. Through the use of albumin-producing, preferably HSA-producing, cells as feeder cells for the conditioning of medium or as host cells, the recloning efficiency and thereby the quantity of clones obtained can be significantly increased. A combination of these approaches is also possible. Through the use of albumin-producing, preferably HSA-producing, cells, an increase in the recloning efficiency can be achieved in serum-free and/or insulin-free medium as well, and in different cell types.
Bibliography:Application Number: US200913062781